MIRTAZAPINE Side Effects

7028027-4 | Multi-organ Failure, Somnolence
on Sep 27, 2010 Male patient from CHILE , 60 years of age, was diagnosed with depression (What is depression?) and was treated with Mirtazapine (View Usage). Patient experienced the following unwanted or unexpected effects: multi-organ failure, somnolence. Mirtazapine dosage: 30 Mg;hs.

7027196-X | Arthralgia, Fluid Retention, Hunger, Joint Swelling, Oedema Peripheral, Pain In Extremity, Weight Increased
Patient was taking Mirtazapine (View Usage). Patient had the following side effects: arthralgia, fluid retention, hunger, joint swelling, oedema peripheral, pain in extremity, weight increased on Sep 14, 2010 from Additional patient health information: Female patient , 43 years of age, weighting 103.6 lb, was diagnosed with depression (What is depression?) and. Mirtazapine dosage: Oral. During the same period patient was treated with DOMPERIDONE (View Domperidone Review and Domperidone Label ), HYOSCINE (View Hyoscine Review and Hyoscine Label ), PROZAC (View Prozac Review and Prozac Label ).

7026614-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Decreased, Blood Cholinesterase Increased, Hepatic Function Abnormal, Hyperlipidaemia, Thymol Turbidity Test Increased
Adverse event was reported on Sep 22, 2010 by a Male patient taking Mirtazapine (View Usage) (Dosage: 15 Mg;qd;po ; 30 Mg;qd;po) was diagnosed with depression (What is depression?) and. Location: JAPAN , 33 years of age, After Mirtazapine was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase decreased, blood cholinesterase increased, hepatic function abnormal, hyperlipidaemia, thymol turbidity test increased. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), BROTIZOLAM (View Brotizolam Review and Brotizolam Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ).

7018902-9 | Arthralgia, Hunger, Joint Swelling, Oedema Peripheral, Weight Increased
on Sep 14, 2010 Female patient from UNITED KINGDOM , 43 years of age, weighting 103.6 lb, was diagnosed with depression (What is depression?) and was treated with Mirtazapine (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, hunger, joint swelling, oedema peripheral, weight increased. Mirtazapine dosage: . During the same period patient was treated with DOMPERIDONE (View Domperidone Review and Domperidone Label ), HYOSCINE (View Hyoscine Review and Hyoscine Label ), PROZAC (View Prozac Review and Prozac Label ).


7018900-5 | Arthralgia, Hunger, Joint Swelling, Oedema Peripheral, Weight Increased
on Sep 14, 2010 Female patient from UNITED KINGDOM , 43 years of age, weighting 103.6 lb, was diagnosed with depression (What is depression?) and was treated with Mirtazapine (View Usage). Patient had the following side effects: arthralgia, hunger, joint swelling, oedema peripheral, weight increased. Mirtazapine dosage: . During the same period patient was treated with DOMPERIDONE (View Domperidone Review and Domperidone Label ), HYOSCINE (View Hyoscine Review and Hyoscine Label ), PROZAC (View Prozac Review and Prozac Label ).

7016761-1 | Serotonin Syndrome
Patient was taking Mirtazapine (View Usage). After Mirtazapine was administered, patient had the following side effects: serotonin syndrome on Sep 14, 2010 from AUSTRALIA Additional patient health information: Male patient , 30 years of age, was diagnosed with major depression and. Mirtazapine dosage: 15 Mg Daiy. During the same period patient was treated with SERTRALINE HYDROCHLORIDE (200 Md Daily) (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ). Patient was hospitalized.

7016593-4 | Activation Syndrome, Agitation, Akathisia, Anxiety, Headache, Impulsive Behaviour, Insomnia, Irritability, Restlessness
Adverse event was reported on Sep 16, 2010 by a Male patient taking Mirtazapine (View Usage) (Dosage: 15 Mg; Qd; Po, 30 Mg; Qd; Po) was diagnosed with depression (What is depression?) and. Location: JAPAN , 62 years of age, Patient experienced the following unwanted or unexpected effects: activation syndrome, agitation, akathisia, anxiety (What is anxiety?), headache (What is headache?), impulsive behaviour, insomnia, irritability, restlessness. Patient was hospitalized.

7016371-6 | Arthralgia, Fluid Retention, Hunger, Joint Swelling, Oedema Peripheral, Weight Increased
on Sep 14, 2010 Female patient from UNITED KINGDOM , 43 years of age, was diagnosed with depression (What is depression?) and was treated with Mirtazapine (View Usage). Patient had the following side effects: arthralgia, fluid retention, hunger, joint swelling, oedema peripheral, weight increased. Mirtazapine dosage: 45 Mg;po. During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), HYOSCINE (View Hyoscine Review and Hyoscine Label ), HYDROBROMIDE (View Hydrobromide Review and Hydrobromide Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ).

7015623-3 | Blood Creatine Phosphokinase Increased, Movement Disorder, Myalgia, Pain, Rhabdomyolysis
on Sep 14, 2010 Male patient from JAPAN , 36 years of age, was diagnosed with depression (What is depression?) and was treated with Mirtazapine (View Usage). After Mirtazapine was administered, patient had the following side effects: blood creatine phosphokinase increased, movement disorder (What is movement disorder?), myalgia, pain (What is pain?), rhabdomyolysis. Mirtazapine dosage: 15 Mg;qd;po. During the same period patient was treated with FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), ETIZOLAM (View Etizolam Review and Etizolam Label ), BROTIZOLAM (View Brotizolam Review and Brotizolam Label ), FLURAZEPAM HYDROCHLORIDE (View Flurazepam Hydrochloride Review and Flurazepam Hydrochloride Label ), DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

7012324-2 | Arterial Haemorrhage, Cardio-respiratory Arrest, Cartilage Injury, Dementia, Depression, Facial Bones Fracture, Insomnia
Patient was taking Mirtazapine (View Usage). Patient experienced the following unwanted or unexpected effects: arterial haemorrhage, cardio-respiratory arrest, cartilage injury, dementia (What is dementia?), depression (What is depression?), facial bones fracture, insomnia on Sep 16, 2010 from JAPAN Additional patient health information: Male patient , 70 years of age, was diagnosed with depression (What is depression?) and. Mirtazapine dosage: 15 Mg;qd;po; 30 Mg;qd;po; 45 Mg;qd;po. During the same period patient was treated with PAROXETINE HYDROCHLORIDE HYDRATE (CON.) (View Paroxetine Hydrochloride Hydrate (con.) Review and Paroxetine Hydrochloride Hydrate (con.) Label ), TETRAMIDE (CON.) (View Tetramide (con.) Review and Tetramide (con.) Label ), CLOMIPRAMINE HYDROCHLORIDE (CON.) (View Clomipramine Hydrochloride (con.) Review and Clomipramine Hydrochloride (con.) Label ), MIANSERIN HYDROCHLORIDE (CON.) (View Mianserin Hydrochloride (con.) Review and Mianserin Hydrochloride (con.) Label ), SULPIRIDE (CON.) (View Sulpiride (con.) Review and Sulpiride (con.) Label ).

7009423-8 | Abnormal Behaviour, Agitation, Cognitive Disorder, Delirium, Hyperhidrosis, Mydriasis, Myoclonus, Posturing
Adverse event was reported on Sep 06, 2010 by a Male patient taking Mirtazapine (View Usage) (Dosage: 15-30mg - Daily -) was diagnosed with major depression and. Location: AUSTRALIA , 30 years of age, Patient had the following side effects: abnormal behaviour, agitation, cognitive disorder, delirium, hyperhidrosis, mydriasis, myoclonus, posturing. During the same period patient was treated with SERTRALINE HYDROCHLORIDE (200 Mg) (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ). Patient was hospitalized.

7008757-0 | Cardiac Arrest, Respiratory Disorder
on Sep 15, 2010 Male patient from FRANCE , 35 years of age, was diagnosed with anxiety (What is anxiety?) and was treated with Mirtazapine (View Usage). After Mirtazapine was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), respiratory disorder. Mirtazapine dosage: 15 Mg; ; Po. During the same period patient was treated with SOLIAN (AMISULPRIDE) (600 Mg; Qd; Po) (View Solian (amisulpride) Review and Solian (amisulpride) Label ), HALOPERIDOL DECANOATE (5 Df; ; Im) (View Haloperidol Decanoate Review and Haloperidol Decanoate Label ), LOXAPINE (300 Gtt; Qd; Po) (View Loxapine Review and Loxapine Label ), TERCIAN (CYAMEMAZINE) (300 Gtt; Qd; Po) (View Tercian (cyamemazine) Review and Tercian (cyamemazine) Label ), LORAZEPAM (2.5 Mg; Qd; Po) (View Lorazepam Review and Lorazepam Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), LEPTICUR (View Lepticur Review and Lepticur Label ). Patient was hospitalized.

7008112-3 | Arthralgia, Fluid Retention, Hunger, Joint Swelling, Oedema Peripheral, Pain, Pain In Extremity, Weight Increased
on Sep 14, 2010 Female patient from UNITED KINGDOM , 43 years of age, weighting 103.6 lb, was diagnosed with depression (What is depression?) and was treated with Mirtazapine (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, fluid retention, hunger, joint swelling, oedema peripheral, pain (What is pain?), pain in extremity, weight increased. Mirtazapine dosage: Po. During the same period patient was treated with DOMPERIDONE (View Domperidone Review and Domperidone Label ), HYOSCINE (View Hyoscine Review and Hyoscine Label ), PROZAC (View Prozac Review and Prozac Label ).

7007971-8 | Acidosis, Dyspnoea, Hyperhidrosis, Lung Disorder, Sepsis
Patient was taking Mirtazapine (View Usage). Patient had the following side effects: acidosis, dyspnoea, hyperhidrosis, lung disorder, sepsis (What is sepsis?) on Sep 15, 2010 from FRANCE Additional patient health information: Female patient , 60 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Mirtazapine dosage: 30 Mg;qpm;po. During the same period patient was treated with REMICADE (5 Mg/kg;unk;iv) (View Remicade Review and Remicade Label ), NOVATREX (METHOTREXATE) (METHOTREXATE) (6 Df;qw;po) (View Novatrex (methotrexate) (methotrexate) Review and Novatrex (methotrexate) (methotrexate) Label ), PREDNISONE (14 Mg;qd;po : 28 Mg;qd) (View Prednisone Review and Prednisone Label ), FOLIC ACID (5 Mg;tiw;po) (View Folic Acid Review and Folic Acid Label ), TRANXENE (10 Mg;qd;po) (View Tranxene Review and Tranxene Label ), ATARAX (300 Mg;qd;po) (View Atarax Review and Atarax Label ), LIPANOR (CIPROFIBRATE) (100 Mg;qd;po) (View Lipanor (ciprofibrate) Review and Lipanor (ciprofibrate) Label ), CALCIUM CARBONATE (500 Mg;qd) (View Calcium Carbonate Review and Calcium Carbonate Label ). Patient was hospitalized.

7007520-4 | Headache, Inappropriate Antidiuretic Hormone Secretion, Malaise, Vomiting
Adverse event was reported on Sep 08, 2010 by a Female patient taking Mirtazapine (View Usage) (Dosage: 30 Mg; Qd; Po) was diagnosed with depression (What is depression?) and. Location: JAPAN , 64 years of age, After Mirtazapine was administered, patient had the following side effects: headache (What is headache?), inappropriate antidiuretic hormone secretion, malaise, vomiting. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), HEVACIZUMAB (View Hevacizumab Review and Hevacizumab Label ), LOXOPROFEN SODIUM (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ), HYDRATE (View Hydrate Review and Hydrate Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ). Patient was hospitalized.

7007203-0 | Arrhythmia, Blood Pressure Decreased, Cardiac Arrest, Respiratory Disorder
on Sep 08, 2010 Male patient from FRANCE , 35 years of age, was diagnosed with anxiety (What is anxiety?) and was treated with Mirtazapine (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), blood pressure decreased, cardiac arrest (What is cardiac arrest?), respiratory disorder. Mirtazapine dosage: 15 Mg; Po. During the same period patient was treated with SOLIAN (AMISULPRIDE) (600 Mg;qd;po) (View Solian (amisulpride) Review and Solian (amisulpride) Label ), HALDOL DECANOAS (HALOPERIDOL DECANOATE) (5 Df; Im) (View Haldol Decanoas (haloperidol Decanoate) Review and Haldol Decanoas (haloperidol Decanoate) Label ), LOXAPINE (300 Gtt;qd;po) (View Loxapine Review and Loxapine Label ), TERCIAN (CYAMEMAZINE) (300 Gtt; Qd; Po) (View Tercian (cyamemazine) Review and Tercian (cyamemazine) Label ), LORAZEPAM (2.5 Mg;qd;po) (View Lorazepam Review and Lorazepam Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), LEPTICUR (View Lepticur Review and Lepticur Label ). Patient was hospitalized.

7007202-9 | Fall, Malaise, Movement Disorder, Poor Quality Sleep, Somnolence, Tremor
on Sep 06, 2010 Female patient from JAPAN , 33 years of age, was diagnosed with depression (What is depression?), insomnia, anxiety (What is anxiety?), tension and was treated with Mirtazapine (View Usage). Patient had the following side effects: fall (What is fall?), malaise, movement disorder (What is movement disorder?), poor quality sleep, somnolence, tremor. Mirtazapine dosage: 7.5 Mg; Po. During the same period patient was treated with QUAZEPAM (15 Mg;qd;po) (View Quazepam Review and Quazepam Label ), BROMAZEPAM (BROMAZEPAM) (12 Mg;qd;po) (View Bromazepam (bromazepam) Review and Bromazepam (bromazepam) Label ), TRAZODONE HYDROCHLORIDE (View Trazodone Hydrochloride Review and Trazodone Hydrochloride Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ).

7006405-7 | Dysarthria, Hypoxia, Lung Disorder, Movement Disorder, Speech Disorder, Suicide Attempt
Patient was taking Mirtazapine (View Usage). After Mirtazapine was administered, patient had the following side effects: dysarthria, hypoxia, lung disorder, movement disorder (What is movement disorder?), speech disorder, suicide attempt on Sep 03, 2010 from FRANCE Additional patient health information: Female patient , 29 years of age, . Mirtazapine dosage: 2 Df; Qd; Po. During the same period patient was treated with EFFEXOR (300 Mg; Qd; Po, 375 Mg; Qd; Po, 225 Mg; Qd; Po) (View Effexor Review and Effexor Label ), ATARAX (300 Mg; Qd; Po) (View Atarax Review and Atarax Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), IMOVANE (View Imovane Review and Imovane Label ).

7006326-X | Acute Hepatic Failure
Adverse event was reported on Sep 08, 2010 by a Female patient taking Mirtazapine (View Usage) (Dosage: 15 Mg, Qpm) was diagnosed with insomnia, depression (What is depression?) and. Location: UNITED KINGDOM , 56 years of age, Patient experienced the following unwanted or unexpected effects: acute hepatic failure. During the same period patient was treated with DULOXETINE (60 Mg, Daily) (View Duloxetine Review and Duloxetine Label ). Patient was hospitalized.

6986126-7 | Loss Of Consciousness, Malaise, Palpitations, Syncope
on Aug 30, 2010 Female patient from , 54 years of age, weighting 125.7 lb, was diagnosed with depression (What is depression?) and was treated with Mirtazapine (View Usage). Patient had the following side effects: loss of consciousness, malaise, palpitations, syncope. Mirtazapine dosage: 30mg, 2 Doses, Oral.

6980365-7 | Completed Suicide
on Sep 02, 2010 Male patient from JAPAN , 58 years of age, was diagnosed with depression (What is depression?) and was treated with Mirtazapine (View Usage). After Mirtazapine was administered, patient had the following side effects: completed suicide. Mirtazapine dosage: 15 Mg; Qd; Po. During the same period patient was treated with PAROXETINE HYDROCHLORIDE (View Paroxetine Hydrochloride Review and Paroxetine Hydrochloride Label ).

6980345-1 | Alanine Aminotransferase Increased, Anxiety, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Fatigue, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Liver Disorder, Oedema Peripheral
Patient was taking Mirtazapine (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anxiety (What is anxiety?), aspartate aminotransferase increased, blood bilirubin increased, fatigue, gamma-glutamyltransferase increased, hepatic function abnormal, liver disorder, oedema peripheral on Aug 30, 2010 from JAPAN Additional patient health information: Female patient , 47 years of age, was diagnosed with anxiety (What is anxiety?), irritability, insomnia and. Mirtazapine dosage: 15 Mg; Qd; Po, 30 Mg; Qd; Po, 45 Mg; Qd; Po. During the same period patient was treated with QUETIAPINE FUMARATE (100 Mg; Qd; Po, 400 Mg; Qd; Po, 500 Mg; Qd; Po, 600 Mg; Qd; Po, 350 Mg; Qd; Po) (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ).

6980344-X | Erythema, Erythema Multiforme, Feeling Abnormal, Malaise, Restlessness, Toxic Skin Eruption
Adverse event was reported on Sep 01, 2010 by a Female patient taking Mirtazapine (View Usage) (Dosage: 15 Mg; Qd; Po) was diagnosed with depression (What is depression?) and. Location: JAPAN , 68 years of age, Patient had the following side effects: erythema, erythema multiforme, feeling abnormal, malaise, restlessness, toxic skin eruption. During the same period patient was treated with ETHYL LOFLAZEPATE (View Ethyl Loflazepate Review and Ethyl Loflazepate Label ), LEVOMEPROMAZINE MALEATE (View Levomepromazine Maleate Review and Levomepromazine Maleate Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), ETIZOLAM (View Etizolam Review and Etizolam Label ).

6980319-0 | Back Pain, Blood Triglycerides Increased, Conversion Disorder, Hypercholesterolaemia, Intentional Self-injury, Low Density Lipoprotein Increased, Mental Status Changes, Nausea
on Sep 01, 2010 Male patient from FRANCE , 49 years of age, was diagnosed with depression (What is depression?) and was treated with Mirtazapine (View Usage). After Mirtazapine was administered, patient had the following side effects: back pain (What is back pain?), blood triglycerides increased, conversion disorder, hypercholesterolaemia, intentional self-injury, low density lipoprotein increased, mental status changes, nausea (What is nausea?). Mirtazapine dosage: 15 Mg; Qd; Po, 15 Mg; Bid; Po. During the same period patient was treated with ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), TETRAZEPAM (View Tetrazepam Review and Tetrazepam Label ), LYSANXIA (View Lysanxia Review and Lysanxia Label ), TANAKAN (View Tanakan Review and Tanakan Label ), VASTAREL (View Vastarel Review and Vastarel Label ), ROPINIROLE HYDROCHLORIDE (View Ropinirole Hydrochloride Review and Ropinirole Hydrochloride Label ).

6980286-X | Amnesia, Fatigue, Feeling Abnormal
on Aug 30, 2010 Male patient from JAPAN , 52 years of age, was diagnosed with depression (What is depression?), insomnia and was treated with Mirtazapine (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, fatigue, feeling abnormal. Mirtazapine dosage: 15 Mg; Qd; Po, 30 Mg; Qd; Po. During the same period patient was treated with HALCION (0.5 Mg; Qd; Po) (View Halcion Review and Halcion Label ).

6979475-X | Vomiting
Patient was taking Mirtazapine (View Usage). Patient had the following side effects: vomiting on Sep 10, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 130.0 lb, was diagnosed with pain (What is pain?) and. Mirtazapine dosage: 1 Pill Every Night Once 047.

6973967-5 |
Adverse event was reported on Aug 30, 2010 by a Male patient taking Mirtazapine (View Usage) (Dosage: ) . Location: SWEDEN , 26 years of age, . During the same period patient was treated with ALCOHOL (View Alcohol Review and Alcohol Label ).

6973964-X |
on Aug 30, 2010 Male patient from SWEDEN , 25 years of age, was treated with Mirtazapine (View Usage). . Mirtazapine dosage: .

6973576-8 | Malaise, Palpitations, Syncope
on Aug 27, 2010 Female patient from UNITED KINGDOM , 54 years of age, weighting 125.7 lb, was diagnosed with depression (What is depression?) and was treated with Mirtazapine (View Usage). Patient had the following side effects: malaise, palpitations, syncope. Mirtazapine dosage: .

6973575-6 | Malaise, Palpitations, Syncope
Patient was taking Mirtazapine (View Usage). After Mirtazapine was administered, patient had the following side effects: malaise, palpitations, syncope on Aug 27, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 54 years of age, weighting 125.7 lb, was diagnosed with depression (What is depression?) and. Mirtazapine dosage: .

6973548-3 | Hyponatraemia
Adverse event was reported on Aug 26, 2010 by a Female patient taking Mirtazapine (View Usage) (Dosage: ) was diagnosed with depression (What is depression?), hypertension, hyperuricaemia, cerebrovascular accident, dyslipidaemia, reflux oesophagitis, type 2 diabetes mellitus and. Location: GERMANY , 56 years of age, weighting 191.8 lb, Patient experienced the following unwanted or unexpected effects: hyponatraemia. During the same period patient was treated with TELMISARTAN AND HYDROCHLOROTHIAZIDE (1 Tablette Enthalt 80mg Telmisartan Und 12.5mg Hct) (View Telmisartan And Hydrochlorothiazide Review and Telmisartan And Hydrochlorothiazide Label ), DELMUNO (1 Tablette Enthalt 5mg Felodipin Und 5mg Ramipril) (View Delmuno Review and Delmuno Label ), ALLOPURINOL HEXAL (View Allopurinol Hexal Review and Allopurinol Hexal Label ), METOHEXAL /00376902/ (View Metohexal /00376902/ Review and Metohexal /00376902/ Label ), ISCOVER (View Iscover Review and Iscover Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), SIOFOR (View Siofor Review and Siofor Label ). Patient was hospitalized.

6973547-1 | Hyponatraemia
on Aug 26, 2010 Female patient from GERMANY , 56 years of age, weighting 191.8 lb, was diagnosed with depression (What is depression?), hypertension, hyperuricaemia, cerebrovascular accident, dyslipidaemia, reflux oesophagitis, type 2 diabetes mellitus and was treated with Mirtazapine (View Usage). Patient had the following side effects: hyponatraemia. Mirtazapine dosage: . During the same period patient was treated with TELMISARTAN (1 Tablette Enthalt 80mg Telmisartan Und 12.5mg Hct) (View Telmisartan Review and Telmisartan Label ), DELMUNO (1 Tablette Enthalt 5mg Felodipin Und 5mg Ramipril) (View Delmuno Review and Delmuno Label ), ALLOPURINOL HEXAL (View Allopurinol Hexal Review and Allopurinol Hexal Label ), METOHEXAL /00376902/ (View Metohexal /00376902/ Review and Metohexal /00376902/ Label ), ISCOVER (View Iscover Review and Iscover Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), SIOFOR (View Siofor Review and Siofor Label ). Patient was hospitalized.

6971822-8 | Autoimmune Hepatitis, Faeces Discoloured, Fibrosis, Gallbladder Cancer, Hepatic Function Abnormal, Hepatotoxicity, Jaundice, Liver Disorder
on Aug 20, 2010 Male patient from , 68 years of age, weighting 207.2 lb, was diagnosed with depression (What is depression?) and was treated with Mirtazapine (View Usage). After Mirtazapine was administered, patient had the following side effects: autoimmune hepatitis, faeces discoloured, fibrosis, gallbladder cancer (What is gallbladder cancer?), hepatic function abnormal, hepatotoxicity, jaundice (What is jaundice?), liver disorder. Mirtazapine dosage: 30mg, Daily, Oral. During the same period patient was treated with TREVILOR 75 (75mg, Daily, Oral) (View Trevilor 75 Review and Trevilor 75 Label ), BISOPROLOL 2.5MG (View Bisoprolol 2.5mg Review and Bisoprolol 2.5mg Label ), THRONAJOD 50 HENNING (LEVOTHYROXINE SODIUM/POTASSIUM IODIDE) 50MCG (View Thronajod 50 Henning (levothyroxine Sodium/potassium Iodide) 50mcg Review and Thronajod 50 Henning (levothyroxine Sodium/potassium Iodide) 50mcg Label ). Patient was hospitalized.

6971780-6 | Abnormal Behaviour, Aggression, Anxiety, Crying, Decreased Interest, Dystonia, Feeling Guilty, Nervousness, Social Phobia
Patient was taking Mirtazapine (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, aggression, anxiety (What is anxiety?), crying, decreased interest, dystonia (What is dystonia?), feeling guilty, nervousness, social phobia on Aug 31, 2010 from JAPAN Additional patient health information: Male patient , 39 years of age, was diagnosed with depression (What is depression?), insomnia and. Mirtazapine dosage: 15 Mg; Hs; Po, 7.5 Mg; Qd; Po. During the same period patient was treated with ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ).

6971779-X | Akathisia, Asphyxia, Completed Suicide, Malaise
Adverse event was reported on Aug 30, 2010 by a Female patient taking Mirtazapine (View Usage) (Dosage: 15 Mg; Po, 30 Mg; Po, 45 Mg; Po) was diagnosed with depression (What is depression?) and. Location: JAPAN , 40 years of age, Patient had the following side effects: akathisia, asphyxia, completed suicide, malaise. During the same period patient was treated with QUAZEPAM (View Quazepam Review and Quazepam Label ), FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ).

6971776-4 | Alcohol Use, Automatism, Dysarthria, Hypoxia, Lung Disorder, Speech Disorder, Suicide Attempt
on Aug 31, 2010 Female patient from FRANCE , 29 years of age, was treated with Mirtazapine (View Usage). After Mirtazapine was administered, patient had the following side effects: alcohol use, automatism, dysarthria, hypoxia, lung disorder, speech disorder, suicide attempt. Mirtazapine dosage: 2 Df; Qd; Po, ; Po. During the same period patient was treated with EFFEXOR (300 Mg; Qd; Po, 225 Mg; Qd; Po, ; Po) (View Effexor Review and Effexor Label ), ATARAX (300 Mg; Qd; Po) (View Atarax Review and Atarax Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), IMOVANE (View Imovane Review and Imovane Label ).

6970414-4 | Palpitations, Syncope
on Aug 27, 2010 Female patient from UNITED KINGDOM , 54 years of age, was diagnosed with depression (What is depression?) and was treated with Mirtazapine (View Usage). Patient experienced the following unwanted or unexpected effects: palpitations, syncope. Mirtazapine dosage: 30 Mg; Po.

6970203-0 | Overdose, Poisoning
Patient was taking Mirtazapine (View Usage). Patient had the following side effects: overdose, poisoning (What is poisoning?) on Aug 30, 2010 from SWEDEN Additional patient health information: Male patient , 26 years of age, . Mirtazapine dosage: . During the same period patient was treated with OXYBATE SODIUM (View Oxybate Sodium Review and Oxybate Sodium Label ).

6970202-9 | Overdose, Poisoning
Adverse event was reported on Aug 30, 2010 by a Male patient taking Mirtazapine (View Usage) (Dosage: ) . Location: SWEDEN , 25 years of age, After Mirtazapine was administered, patient had the following side effects: overdose, poisoning (What is poisoning?). During the same period patient was treated with OXYBATE SODIUM (View Oxybate Sodium Review and Oxybate Sodium Label ).

6969389-3 | Depression, Disease Recurrence
on Aug 23, 2010 Female patient from DENMARK , 83 years of age, was diagnosed with depression (What is depression?) and was treated with Mirtazapine (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), disease recurrence. Mirtazapine dosage: 30 Mg; Qd; Po. During the same period patient was treated with SERTRALINE HYDROCHLORIDE (25 Mg; Qd; Po) (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), VENLAFAXINE HYDROCHLORIDE (75 Mg; Qd; Po) (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), CITALOPRAM HYDROBROMIDE (Po) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ).

6969126-2 | Abnormal Behaviour, Agitation, Confusional State, Delirium, Hyperhidrosis, Hyperreflexia, Mental Status Changes, Mydriasis, Myoclonus
on Aug 25, 2010 Male patient from AUSTRALIA , 30 years of age, was diagnosed with major depression, sleep disorder (What is sleep disorder?) and was treated with Mirtazapine (View Usage). Patient had the following side effects: abnormal behaviour, agitation, confusional state, delirium, hyperhidrosis, hyperreflexia, mental status changes, mydriasis, myoclonus. Mirtazapine dosage: 15 Mg/day. During the same period patient was treated with SERTRALINE (NGX) (Titrated To 200 Mg, Unk) (View Sertraline (ngx) Review and Sertraline (ngx) Label ), QUETIAPINE (50 Mg, Unk) (View Quetiapine Review and Quetiapine Label ). Patient was hospitalized.

6968417-9 | Atrial Fibrillation, Sleep Apnoea Syndrome
Patient was taking Mirtazapine (View Usage). After Mirtazapine was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), sleep apnoea syndrome on Aug 23, 2010 from UNITED STATES Additional patient health information: Male patient , 62 years of age, weighting 180.0 lb, . Mirtazapine dosage: .

6967417-2 | Anxiety, Decreased Appetite, Dysphagia, Tremor
Adverse event was reported on Aug 26, 2010 by a Female patient taking Mirtazapine (View Usage) (Dosage: 15 Mg; Qd; Po) was diagnosed with depression (What is depression?) and. Location: JAPAN , 78 years of age, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), decreased appetite, dysphagia, tremor. During the same period patient was treated with SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ). Patient was hospitalized.

6964095-3 | Hepatic Function Abnormal, Hyperlipidaemia, Weight Increased
on Aug 25, 2010 Male patient from JAPAN , 33 years of age, was diagnosed with depression (What is depression?) and was treated with Mirtazapine (View Usage). Patient had the following side effects: hepatic function abnormal, hyperlipidaemia, weight increased. Mirtazapine dosage: 15 Mg;qd;po; 30 Mg;qd;po. During the same period patient was treated with LANSOPRANZOLE (View Lansopranzole Review and Lansopranzole Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), HYDROCHLORIDE (View Hydrochloride Review and Hydrochloride Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), BROTIZOLAM (View Brotizolam Review and Brotizolam Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ).

6963861-8 | Asphyxia, Completed Suicide, Condition Aggravated, Movement Disorder, Overdose, Speech Disorder, Stupor, Unresponsive To Stimuli
on Aug 25, 2010 Female patient from JAPAN , 69 years of age, was diagnosed with depression (What is depression?), insomnia and was treated with Mirtazapine (View Usage). After Mirtazapine was administered, patient had the following side effects: asphyxia, completed suicide, condition aggravated, movement disorder (What is movement disorder?), overdose, speech disorder, stupor, unresponsive to stimuli. Mirtazapine dosage: 15 Mg; Po; 45 Mg, Qd, Po. During the same period patient was treated with FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), CHINESE HERBAL MEDICINE (View Chinese Herbal Medicine Review and Chinese Herbal Medicine Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ).

6962379-6 | Hyponatraemia
Patient was taking Mirtazapine (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia on Aug 25, 2010 from GERMANY Additional patient health information: Female patient , 56 years of age, weighting 191.8 lb, was diagnosed with depression (What is depression?), hypertension and. Mirtazapine dosage: . During the same period patient was treated with PRITOR (TELMISARTAN/HCT) (Unit Dose:80mg Telmisartan/12.5mg Hct) (View Pritor (telmisartan/hct) Review and Pritor (telmisartan/hct) Label ), UNIMAX (FELODIPIN/RAMIPRIL) (Unit Dose: 5mg Felodipin/5mg Ramipril) (View Unimax (felodipin/ramipril) Review and Unimax (felodipin/ramipril) Label ). Patient was hospitalized.

6959581-6 | Convulsion, Dizziness, Hepatic Function Abnormal, Hypoaesthesia, Immobile, Liver Disorder, Tremor
Adverse event was reported on Aug 19, 2010 by a Female patient taking Mirtazapine (View Usage) (Dosage: 15 Mg;hs;po) was diagnosed with decreased appetite, depression (What is depression?), insomnia and. Location: JAPAN , 82 years of age, Patient had the following side effects: convulsion, dizziness (What is dizziness?), hepatic function abnormal, hypoaesthesia, immobile, liver disorder, tremor. During the same period patient was treated with LANSOPRAZOLE (CON.) (View Lansoprazole (con.) Review and Lansoprazole (con.) Label ), IRSOGLADINE MALEATE (CON.) (View Irsogladine Maleate (con.) Review and Irsogladine Maleate (con.) Label ), PAROXETINE HYDROCHLORIDE HYDRATE (CON.) (View Paroxetine Hydrochloride Hydrate (con.) Review and Paroxetine Hydrochloride Hydrate (con.) Label ), FLUNITRAZEPAM (CON.) (View Flunitrazepam (con.) Review and Flunitrazepam (con.) Label ), MAGNESIUM OXIDE (CON.) (View Magnesium Oxide (con.) Review and Magnesium Oxide (con.) Label ), SODIUM PICOSULFATE HYDRATE (CON.) (View Sodium Picosulfate Hydrate (con.) Review and Sodium Picosulfate Hydrate (con.) Label ). Patient was hospitalized.

6959551-8 | Restless Legs Syndrome
on Aug 24, 2010 Male patient from GERMANY , 27 years of age, weighting 167.6 lb, was diagnosed with depression (What is depression?), insomnia and was treated with Mirtazapine (View Usage). After Mirtazapine was administered, patient had the following side effects: restless legs syndrome. Mirtazapine dosage: Qd.

6945937-4 | Rhabdomyolysis
on Aug 17, 2010 Female patient from JAPAN , 74 years of age, was diagnosed with pain (What is pain?) and was treated with Mirtazapine (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis. Mirtazapine dosage: 15 Mg;hs;po; 30 Mg;hs;po. During the same period patient was treated with TOLEDOMIN (MILNACIPRAN HYDROCHLORIDE) (25 Mg;bid;po; 50 Mg; Bid;po) (View Toledomin (milnacipran Hydrochloride) Review and Toledomin (milnacipran Hydrochloride) Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), ETIZOLAM (View Etizolam Review and Etizolam Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), MOSAPRIDE CITRATE (View Mosapride Citrate Review and Mosapride Citrate Label ). Patient was hospitalized.

6943090-4 | Hyponatraemia
Patient was taking Mirtazapine (View Usage). Patient had the following side effects: hyponatraemia on Aug 25, 2010 from GERMANY Additional patient health information: Female patient , 56 years of age, weighting 191.8 lb, was diagnosed with depression (What is depression?), hypertension, hyperuricaemia, cerebrovascular accident, dyslipidaemia, reflux oesophagitis, type 2 diabetes mellitus and. Mirtazapine dosage: 22.5 Mg, Qd. During the same period patient was treated with TELMISARTAN AND HYDROCHLOROTHIAZIDE (1 Df, Qd) (View Telmisartan And Hydrochlorothiazide Review and Telmisartan And Hydrochlorothiazide Label ), DELMUNO (1 Df, Qd) (View Delmuno Review and Delmuno Label ), ALLOPURINOL (300 Mg, Unk) (View Allopurinol Review and Allopurinol Label ), METOHEXAL (100 Mg, Bid) (View Metohexal Review and Metohexal Label ), ISCOVER (75 Mg, Qd) (View Iscover Review and Iscover Label ), SIMVASTATIN (40 Mg, Qd) (View Simvastatin Review and Simvastatin Label ), PANTOPRAZOLE SODIUM (40 Mg, Qd) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), SIOFOR (500 Mg, Bid) (View Siofor Review and Siofor Label ). Patient was hospitalized.